IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 1195 
Small font sizeDefault font sizeIncrease font size
Read this article


    Article Cited by others


Effective control of sickle cell disease with hydroxyurea therapy

Singh Harminder, Dulhani Navin, Kumar Bithika Nel, Singh Prabhakar, Tiwari Pawan

Year : 2010| Volume: 42| Issue : 1 | Page no: 32-35

   This article has been cited by
1 Update on the use of hydroxyurea therapy in sickle cell disease
T. E. Wong,A. M. Brandow,W. Lim,R. Lottenberg
Blood. 2014; 124(26): 3850
[Pubmed]  [Google Scholar] [DOI]
2 Hydroxyurea-associated acral erythema in a patient with polycythemia vera
Daniel Butler,Vinod E. Nambudiri,Tina Nandi
American Journal of Hematology. 2014; : n/a
[Pubmed]  [Google Scholar] [DOI]
3 Sickle cell disease in India
Roshan Colah,Malay Mukherjee,Kanjaksha Ghosh
Current Opinion in Hematology. 2014; 21(3): 215
[Pubmed]  [Google Scholar] [DOI]
4 Hydroxyurea Treatment in Transfusion-Dependent ß-Thalassemia Patients
Mohammad Reza Bordbar,Samir Silavizadeh,Sezaneh Haghpanah,Roza Kamfiroozi,Marzieh Bardestani,Mehran Karimi
Iranian Red Crescent Medical Journal. 2014; 16(6)
[Pubmed]  [Google Scholar] [DOI]
5 Comprehensive integrated care for patients with sickle cell disease in a remote aboriginal tribal population in southern India
Vivek Nimgaonkar,Lakshmanan Krishnamurti,Hari Prabhakar,Nandakumar Menon
Pediatric Blood & Cancer. 2013; : n/a
[Pubmed]  [Google Scholar] [DOI]
6 Efficacy of fixed low dose hydroxyurea in Indian children with sickle cell anemia: A single centre experience
Dipti L. Jain,Mohini Apte,Roshan Colah,Vijaya Sarathi,Saumil Desai,Amruta Gokhale,Amol Bhandarwar,Harshwardhan L. Jain,Kanjaksha Ghosh
Indian Pediatrics. 2013; 50(10): 929
[Pubmed]  [Google Scholar] [DOI]
7 Low Fixed-Dose Hydroxyurea in Severely Affected Indian Children with Sickle Cell Disease
Dipty L. Jain,Vijaya Sarathi,Saumil Desai,Manoj Bhatnagar,Abhijit Lodha
Hemoglobin. 2012; 36(4): 323
[Pubmed]  [Google Scholar] [DOI]
8 Unlocking the binding and reaction mechanism of hydroxyurea substrates as biological nitric oxide donors
Vankayala, S.L., Hargis, J.C., Woodcock, H.L.
Journal of Chemical Information and Modeling. 2012; 52(5): 1288-1297
[Pubmed]  [Google Scholar]
9 Unlocking the Binding and Reaction Mechanism of Hydroxyurea Substrates as Biological Nitric Oxide Donors
Sai Lakshmana Vankayala,Jacqueline C. Hargis,H. Lee Woodcock
Journal of Chemical Information and Modeling. 2012; 52(5): 1288
[Pubmed]  [Google Scholar] [DOI]
10 Low fixed-dose hydroxyurea in severely affected Indian children with sickle cell disease
Jain, D.L., Sarathi, V., Desai, S., Bhatnagar, M., Lodha, A.
Hemoglobin. 2012; 36(4): 323-332
[Pubmed]  [Google Scholar]
11 Authorsę reply
Singh, H., Dulhani, N., Kumar, B.N., Singh, P., Tiwari, P.
Indian Journal of Pharmacology. 2011; 43(1): 95
[Pubmed]  [Google Scholar]
12 The novelty of research article: Whose responsibility is it
Beedimani, R.S.
Indian Journal of Pharmacology. 2011; 43(1): 94-95
[Pubmed]  [Google Scholar]
13 Hydroxyurea-induced palmar-plantar erythrodysesthesia in an adult with sickle cell disease
Ramandeep K. Bambrah,Fauzia Rana,Dat C. Pham
Community Oncology. 2011; 8(5): 237
[Pubmed]  [Google Scholar] [DOI]
14 Hydroxyurea-induced palmar-plantar erythrodysesthesia in an adult with sickle cell disease
Bambrah, R.K., Rana, F., Pham, D.C.
Community Oncology. 2011; 8(5): 237-238
[Pubmed]  [Google Scholar]


Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow